Pr Christophe Massard

Specialty

Oncologist, bladder expert, prostate expert

Title

Head of the Early Trials Department (DITEP)

Hospital

Gustave Roussy (Villejuif)

Latest articles

• The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. (Aug 26, 2025)
• Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. (Jul 31, 2025)
• Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. (Jul 29, 2025)
• [Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer]. (Jul 9, 2025)
• First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors. (Jul 1, 2025)